BNC105 is primarily researched for its potential in cancer therapy. It functions as a vascular disrupting agent, targeting and damaging the blood vessels that supply tumors, thereby cutting off their nutrient and oxygen supply. This leads to tumor cell death and can be particularly effective in combination with other cancer treatments like chemotherapy or radiation therapy. Its application is being explored in various types of cancers, including ovarian, renal, and lung cancers, to enhance treatment efficacy and improve patient outcomes.